Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, openWorld, idempotent, and non-destructive. The description adds significant behavioral detail: graceful degradation of LEI/FIGI enrichment, explicit `unresolved` labeling instead of omission, and `figi_candidates` returned when a name matches multiple instruments. These are non-obvious behaviors that materially affect agent expectations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but information-dense, with every sentence adding critical nuance (input formats, source behaviors, failure modes). It is front-loaded with examples and the primary use case. While not as terse as ideal, the volume of disambiguation justifies the length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the complexity (two entity types, multiple external sources, degradation, candidate lists), the description adequately covers all key behaviors an agent needs to call it correctly. No output schema exists, so it explains return elements like `unresolved` and `figi_candidates`. The annotations and schema fill in the rest, leaving no major gaps.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema covers both parameters fully (100% coverage) with detailed enum and descriptions. The description goes further by clarifying subtle semantics: for bonds, the input should be exactly the ISSUER name as printed, not the full noun phrase, and that ticker/CIK/ISIN/name are all acceptable. This prevents common agent errors.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states the exact purpose: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It provides clear examples and explicitly distinguishes itself as the 'FIRST' step for name-to-ID resolution, differentiating it from sibling tools like entity_profile and compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit when-to-use guidance ('Use FIRST whenever you have a name but need an ID') and contextual scenarios (e.g., resolving tickers, CIKs, LEIs). It explains that it replaces 2-3 manual lookups, but does not explicitly name alternative tools for specific cases or state when NOT to use it, so it's slightly short of a full routing guide.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation1/5

The tool set covers many unrelated domains (elevation, finance, prediction markets, AI visibility, etc.) with multiple overlapping tools per domain (e.g., three 'ask_pipeworx' variants, several 'polymarket' tools). An agent would struggle to distinguish which tool to use for a given task.

Naming Consistency2/5

Names follow no consistent pattern: some use snake_case with vague verbs (e.g., 'process', 'run'), others use descriptive but unrelated prefixes ('ai_', 'ask_pipeworx_', 'polymarket_'). There is no uniform verb_noun structure.

Tool Count3/5

With 32 tools, the count is reasonable for a large server, but the vast majority are irrelevant to the server's stated purpose (elevation). This mismatch makes the count inappropriate.

Completeness1/5

The server name 'Open Elevation' implies a focus on elevation data, yet only 2 of 32 tools (get_elevation, get_elevations) are related. There are severe gaps: no area elevation, no geocoding, no terrain analysis. The tool surface is largely off-topic.